National Committee for Quality Assurance
- Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. This updates a previously published measure summary.
- Disease-modifying anti-rheumatic drug therapy for rheumatoid arthritis: percentage of members who were diagnosed with rheumatoid arthritis and who were dispensed at least one ambulatory prescription for a disease modifying anti-rheumatic drug (DMARD). This updates a previously published measure summary.
- Medication reconciliation post-discharge: percentage of discharges from January 1 to December 1 of the measurement year for members 66 years of age and older for whom medications were reconciled on or within 30 days of discharge. This updates a previously published measure summary.
- Osteoporosis management in women who had a fracture: percentage of women 67 to 85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat or prevent osteoporosis in the six months after the fracture. This updates a previously published measure summary.
- Potentially harmful drug-disease interactions in the elderly: percentage of Medicare members 65 years of age and older who have evidence of underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis. This updates a previously published measure summary.
- Use of high-risk medications in the elderly: percentage of Medicare members 66 years of age and older who received at least one high-risk medication. This updates a previously published measure summary.
- Use of high-risk medications in the elderly: percentage of Medicare members 66 years of age and older who received at least two different high-risk medications. This updates a previously published measure summary.
- Use of imaging studies for low back pain: percentage of members with a primary diagnosis of low back pain who did not have an imaging study (plain x-ray, MRI, CT scan) within 28 days of the diagnosis. This updates a previously published measure summary.
No hay comentarios:
Publicar un comentario